“Building AI-driven real-world biological simulations to end terminal disease.”
Contact Us
Investors & Patients
Lee Charles Research is currently seeking participation from accredited investors and will begin enrolling patients in April 2026. To date, the founder has personally invested more than $1,000,000 into the development of research infrastructure and protocols designed to address significant unmet needs in patient care and medical research.
leecharlesresearch.com
